Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis
- PMID: 17362932
- DOI: 10.1016/j.expneurol.2007.01.036
Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis
Abstract
Whether increased levels of matrix metalloproteinases (MMPs) correspond to a role in the pathogenesis of amyotrophic lateral sclerosis (ALS) needs to be determined and it is actively being pursued. Here we present evidence suggesting that MMP-9 contributes to the motor neuron cell death in ALS. We examined the role of MMP-9 in a mouse model of familial ALS and found that lack of MMP-9 increased survival (31%) in G93A SOD1 mice. Also, MMP-9 deficiency in G93A mice significantly attenuated neuronal loss, and reduced neuronal TNF-alpha and FasL immunoreactivities in the lumbar spinal cord. These findings suggest that MMP-9 is an important player in the pathogenesis of ALS. Our data suggest that the mechanism for MMP-9 neurotoxicity in ALS may be by upregulating neuronal TNF-alpha and FasL expression and activation. This study provides new mechanism and suggests that MMP inhibitors may offer a new therapeutic strategy for ALS.
Similar articles
-
MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS.J Neurol Sci. 2010 Jul 15;294(1-2):51-6. doi: 10.1016/j.jns.2010.04.005. Epub 2010 May 4. J Neurol Sci. 2010. PMID: 20441996
-
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.J Neurosci. 2006 Mar 1;26(9):2467-73. doi: 10.1523/JNEUROSCI.5253-05.2006. J Neurosci. 2006. PMID: 16510725 Free PMC article.
-
Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.Neurodegener Dis. 2005;2(5):246-54. doi: 10.1159/000090364. Neurodegener Dis. 2005. PMID: 16909005
-
Matrix metalloproteinases deregulation in amyotrophic lateral sclerosis.J Neurol Sci. 2020 Dec 15;419:117175. doi: 10.1016/j.jns.2020.117175. Epub 2020 Oct 11. J Neurol Sci. 2020. PMID: 33068904 Review.
-
Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?Cells. 2021 Mar 1;10(3):518. doi: 10.3390/cells10030518. Cells. 2021. PMID: 33804386 Free PMC article. Review.
Cited by
-
The wobbler mouse, an ALS animal model.Mol Genet Genomics. 2013 Jun;288(5-6):207-29. doi: 10.1007/s00438-013-0741-0. Epub 2013 Mar 29. Mol Genet Genomics. 2013. PMID: 23539154 Free PMC article. Review.
-
Role of metalloproteases in the CD95 signaling pathways.Front Immunol. 2022 Dec 5;13:1074099. doi: 10.3389/fimmu.2022.1074099. eCollection 2022. Front Immunol. 2022. PMID: 36544756 Free PMC article. Review.
-
Association studies of MMP-9 in Parkinson's disease and amyotrophic lateral sclerosis.PLoS One. 2013 Sep 9;8(9):e73777. doi: 10.1371/journal.pone.0073777. eCollection 2013. PLoS One. 2013. PMID: 24040066 Free PMC article.
-
A glimpse of matrix metalloproteinases in diabetic nephropathy.Curr Med Chem. 2014;21(28):3244-60. doi: 10.2174/0929867321666140716092052. Curr Med Chem. 2014. PMID: 25039784 Free PMC article. Review.
-
Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration.Mol Neurobiol. 2015;51(3):864-77. doi: 10.1007/s12035-014-8731-8. Epub 2014 May 22. Mol Neurobiol. 2015. PMID: 24848512
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous